论文信息 - A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL). - 字舞流文

A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL).

H. Kantarjian | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | C. Dinardo | N. Jain | N. Short | C. Loiselle | A. Ferrajoli | M. Ohanian | K. Sasaki | Ming Zhao | P. Thompson | M. Yilmaz | R. Garris | M. Kwari | M. Konopleva | W. Macaron | Y. Alvarado Valero | Rebecca E. Garris | Yesid Alvarado Valero